Non-Invasive Brain-Computer Interface Combined With Transcranial Electrical Stimulation for Peripheral Facial PalsyStimulation in the Treatment of Peripheral Facial Palsy
Efficacy and Safety of Non-Invasive Brain-Computer Interface Combined With Transcranial Electrical Stimulation in the Treatment of Peripheral Facial Palsy
1 other identifier
interventional
30
1 country
1
Brief Summary
To evaluate the efficacy and safety of treating peripheral facial palsy using a non-invasive brain-computer interface combined with transcranial direct current stimulation (tDCS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2025
CompletedFirst Submitted
Initial submission to the registry
December 25, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
January 8, 2026
December 1, 2025
2.1 years
December 25, 2025
December 25, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Improvement in House-Brackmann (HB) grading
At 0,2,4,8 and 12 weeks.
Sunnybrook Facial Grading System score.
At 0,2,4,8 and 12 weeks.
Static and dynamic facial symmetry scores.
At 0,2,4,8 and 12 weeks.
Degree of facial muscle EMG activation and changes in EEG functional connectivity.
At 0,2,4,8 and 12 weeks.
Secondary Outcomes (1)
Adverse events
At 0,2,4,8 and 12 weeks.
Study Arms (3)
Group A: Standard Therapy
PLACEBO COMPARATORStandard therapy.
Group B: Pulsed Radiofrequency + Standard Therapy
PLACEBO COMPARATORStandard Therapy and Pulsed Radiofrequency Therapy.
Group C:BCI + tDCS + Pulsed Radiofrequency Treatment + Standard Therapy
EXPERIMENTALBCI + tDCS + Pulsed Radiofrequency Treatment + Standard Therapy.
Interventions
1. BCI Therapy: Real-time feedback drives NMES (neuromuscular electrical stimulation) of the target facial muscles. Each session lasts 30 minutes, 3-5 times per week, for a total of 4 weeks. 2. tDCS Therapy: Applied to the regions corresponding to the branches of the facial nerve. A constant current (usually 0.5-2 mA) is delivered for 20-30 minutes per session, 5-20 sessions per course. Standard treatment frequency is once daily, 5-6 times per week, with a continuous course of 2-4 weeks. Each stimulation session typically lasts 20-30 minutes.
Acute-phase "shock" protocol: Within 7 days of onset, a single pulsed radiofrequency treatment is applied to the extracranial segment of the facial nerve. Depending on recovery, the treatment may be repeated 1-2 weeks later. Chronic-phase (sequelae) "shock" protocol: Administered once every 1-4 weeks, for a total of 1-4 sessions.
Includes facial muscle function training, physiotherapy, hot and cold compresses, and neurotrophic drug treatment.
Eligibility Criteria
You may qualify if:
- Aged 18-70 years, regardless of sex.
- Unilateral peripheral facial nerve palsy.
- House-Brackmann (HB) grade II-VI.
- Able to cooperate with target facial movement tasks and provide written informed consent, with intact cognitive function and good communication ability.
- Good skin condition, with no severe skin lesions or facial skin grafts; no implanted electronic devices such as cardiac pacemakers or deep brain stimulators, to avoid electrophysiological interference.
- Non-pregnant and non-lactating women, in accordance with regulatory requirements for minimal-risk research.
You may not qualify if:
- Open facial wounds, active infections, significant skin lesions, or a history of severe allergy.
- Severe cognitive impairment, psychiatric disorders, or inability to comply with study procedures.
- Occurrence of serious adverse events or withdrawal at the patient's request.
- Pregnant or lactating women, or patients unable to use appropriate contraceptive measures during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Peoples's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University
Changzhou, Jiangsu, 213000, China
Related Publications (7)
Soekadar SR, Witkowski M, Birbaumer N, Cohen LG. Enhancing Hebbian Learning to Control Brain Oscillatory Activity. Cereb Cortex. 2015 Sep;25(9):2409-15. doi: 10.1093/cercor/bhu043. Epub 2014 Mar 13.
PMID: 24626608RESULTJitsinthunun T, Li C, Ng TK, Zinboonyahgoon N. Pulsed Radiofrequency Treatment: Evidence for and Applications in Chronic Pain. Pain Physician. 2025 Nov;28(6):467-481.
PMID: 41337760RESULTSam J, Catapano M, Sahni S, Ma F, Abd-Elsayed A, Visnjevac O. Pulsed Radiofrequency in Interventional Pain Management: Cellular and Molecular Mechanisms of Action - An Update and Review. Pain Physician. 2021 Dec;24(8):525-532.
PMID: 34793641RESULTLiu Z, Xie D, Wen X, Wang R, Yang Q, Liu H, Shao Y, Liu T. Peripheral Repetitive Transcranial Magnetic Stimulation(rTMS) for Idiopathic Facial Nerve Palsy: A Prospective, Randomized Controlled Trial. Neural Plast. 2022 Jul 13;2022:7536783. doi: 10.1155/2022/7536783. eCollection 2022.
PMID: 35875789RESULTLi D, Li R, Song Y, Qin W, Sun G, Liu Y, Bao Y, Liu L, Jin L. Effects of brain-computer interface based training on post-stroke upper-limb rehabilitation: a meta-analysis. J Neuroeng Rehabil. 2025 Mar 3;22(1):44. doi: 10.1186/s12984-025-01588-x.
PMID: 40033447RESULTCervera MA, Soekadar SR, Ushiba J, Millan JDR, Liu M, Birbaumer N, Garipelli G. Brain-computer interfaces for post-stroke motor rehabilitation: a meta-analysis. Ann Clin Transl Neurol. 2018 Mar 25;5(5):651-663. doi: 10.1002/acn3.544. eCollection 2018 May.
PMID: 29761128RESULTLefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, Filipovic SR, Grefkes C, Hasan A, Hummel FC, Jaaskelainen SK, Langguth B, Leocani L, Londero A, Nardone R, Nguyen JP, Nyffeler T, Oliveira-Maia AJ, Oliviero A, Padberg F, Palm U, Paulus W, Poulet E, Quartarone A, Rachid F, Rektorova I, Rossi S, Sahlsten H, Schecklmann M, Szekely D, Ziemann U. Corrigendum to "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)" [Clin. Neurophysiol. 131 (2020) 474-528]. Clin Neurophysiol. 2020 May;131(5):1168-1169. doi: 10.1016/j.clinph.2020.02.003. Epub 2020 Feb 19. No abstract available.
PMID: 32122766RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- phD
Study Record Dates
First Submitted
December 25, 2025
First Posted
January 8, 2026
Study Start
November 30, 2025
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
January 8, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared because the study involves sensitive clinical and neurophysiological data, and full de-identification cannot be guaranteed without compromising participant privacy. In addition, the informed consent obtained from participants did not include provisions for public data sharing.